Literature DB >> 6195185

O and H serotyping of Pseudomonas cepacia.

A Heidt, H Monteil, C Richard.   

Abstract

Procedures for the preparation, absorption, and titration of Pseudomonas cepacia O and H rabbit antisera are described. Seven O antigens (O1 to O7) for the slide agglutination test and five H antigens (H1, H3, H5, H6, and H7) for the agglutination and H immobilization tests were determined. Nearly 300 strains of P. cepacia isolated from hospitalized patients (a majority from Strasbourg hospitals) were serotyped. The use of P. cepacia serotyping as an epidemiological tool, especially in outbreak situations, was emphasized. Difficulties in obtaining monospecific H antisera are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6195185      PMCID: PMC270889          DOI: 10.1128/jcm.18.3.738-740.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  4 in total

1.  Preparation of agglutinating antisera specific for the flagellar antigens of Pseudomonas aeruginosa.

Authors:  T L Pitt
Journal:  J Med Microbiol       Date:  1981-08       Impact factor: 2.472

2.  [Antigenic study of Serratia marcescens isolated in France. I.--Antigens: individualization of six new H factors (author's transl)].

Authors:  S Le Minor; F Pigache
Journal:  Ann Microbiol (Paris)       Date:  1977 Aug-Sep

3.  [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].

Authors:  R Minck; S Le Minor; F Pigache; A Dammron; E Reeb; M Kohen; A Le Faou
Journal:  Pathol Biol (Paris)       Date:  1980-10

4.  [Phenotype characteristics of 100 strains of Pseudomonas cepacia. Proposition of a biovars classification (author's transl)].

Authors:  C Richard; H Monteil; F Mégraud; R Chatelain; B Laurent
Journal:  Ann Biol Clin (Paris)       Date:  1981       Impact factor: 0.459

  4 in total
  15 in total

1.  Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks.

Authors:  M Okazaki; T Watanabe; K Morita; Y Higurashi; K Araki; N Shukuya; S Baba; N Watanabe; T Egami; N Furuya; M Kanamori; S Shimazaki; H Uchimura
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex.

Authors:  Arlene D Vinion-Dubiel; Theodore Spilker; Charles R Dean; Henri Monteil; John J LiPuma; Joanna B Goldberg
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

Review 3.  Use of ribotyping in epidemiological surveillance of nosocomial outbreaks.

Authors:  E H Bingen; E Denamur; J Elion
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

Review 4.  Current status of Pseudomonas cepacia typing systems.

Authors:  C S Rabkin; W R Jarvis; W J Martone
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

5.  Reconstitution of O-specific lipopolysaccharide expression in Burkholderia cenocepacia strain J2315, which is associated with transmissible infections in patients with cystic fibrosis.

Authors:  Ximena Ortega; Tracey A Hunt; Slade Loutet; Arlene D Vinion-Dubiel; Anup Datta; Biswa Choudhury; Joanna B Goldberg; Russell Carlson; Miguel A Valvano
Journal:  J Bacteriol       Date:  2005-02       Impact factor: 3.490

6.  Molecular analysis of hemolytic and phospholipase C activities of Pseudomonas cepacia.

Authors:  M L Vasil; D P Krieg; J S Kuhns; J W Ogle; V D Shortridge; R M Ostroff; A I Vasil
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

Review 7.  Microbiology of airway disease in patients with cystic fibrosis.

Authors:  P H Gilligan
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

Review 8.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

9.  Arbitrarily primed polymerase chain reaction as a rapid method to differentiate crossed from independent Pseudomonas cepacia infections in cystic fibrosis patients.

Authors:  E H Bingen; M Weber; J Derelle; N Brahimi; N Y Lambert-Zechovsky; M Vidailhet; J Navarro; J Elion
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

10.  Subgrouping of Pseudomonas cepacia by cellular fatty acid composition.

Authors:  G M Mukwaya; D F Welch
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.